A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.
Mol Ther. 2021 Jul 7;29(7):2219-2226. doi: 10.1016/j.ymthe.2021.05.004. Epub 2021 May 14.
Mol Ther. 2021.
PMID: 33992805
Free PMC article.